DnB Asset Management
ITCI

DnB Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

DnB Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-87,569
Closed -$7.31M – 774
2024
Q4 		$7.31M Sell
87,569
-10,497
-11% -$863K 0.03% 320
2024
Q3 		$7.18M Buy
98,066
+17,911
+22% +$1.35M 0.03% 322
2024
Q2 		$5.48M Buy
80,155
+13,402
+20% +$930K 0.03% 341
2024
Q1 		$4.62M Buy
66,753
+56,453
+548% +$3.88M 0.02% 364
2023
Q4 		$738K Sell
10,300
-1,894
-16% -$109K ﹤0.01% 611
2023
Q3 		$635K Sell
12,194
-2,079
-15% -$121K ﹤0.01% 626
2023
Q2 		$904K Buy
14,273
+4,151
+41% +$259K 0.01% 614
2023
Q1 		$548K Buy
+10,122
New +$489K ﹤0.01% 627

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return